SignatureFD’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-670
| Closed | -$19.9K | – | 3286 |
|
|
2023
Q4 | $19.9K | Buy |
670
+175
| +35% | +$3.48K | ﹤0.01% | 1929 |
|
|
2023
Q3 | $7.86K | Buy |
495
+335
| +209% | +$5.57K | ﹤0.01% | 2328 |
|
|
2023
Q2 | $3.02K | Buy |
160
+99
| +162% | +$1.17K | ﹤0.01% | 2670 |
|
|
2023
Q1 | $234 | Buy |
61
+13
| +27% | +$55 | ﹤0.01% | 3176 |
|
|
2022
Q4 | $238 | Hold |
48
| – | – | ﹤0.01% | 3179 |
|
|
2022
Q3 | $0 | Buy |
+48
| New | +$253 | ﹤0.01% | 3411 |
|
|
2022
Q2 | – | Sell |
-253
| Closed | -$1K | – | 3399 |
|
|
2022
Q1 | $1K | Hold |
253
| – | – | ﹤0.01% | 3094 |
|
|
2021
Q4 | $2K | Hold |
253
| – | – | ﹤0.01% | 2824 |
|
|
2021
Q3 | $1K | Sell |
253
-18
| -7% | -$104 | ﹤0.01% | 2972 |
|
|
2021
Q2 | $2K | Hold |
271
| – | – | ﹤0.01% | 2642 |
|
|
2021
Q1 | $2K | Hold |
271
| – | – | ﹤0.01% | 2557 |
|
|
2020
Q4 | $2K | Sell |
271
-301
| -53% | -$1.76K | ﹤0.01% | 2342 |
|
|
2020
Q3 | $2K | Hold |
572
| – | – | ﹤0.01% | 2307 |
|
|
2020
Q2 | $3K | Sell |
572
-35
| -6% | -$149 | ﹤0.01% | 2044 |
|
|
2020
Q1 | $2K | Hold |
607
| – | – | ﹤0.01% | 2028 |
|
|
2019
Q4 | $3K | Sell |
607
-91
| -13% | -$309 | ﹤0.01% | 1837 |
|
|
2019
Q3 | $2K | Hold |
698
| – | – | ﹤0.01% | 1883 |
|
|
2019
Q2 | $2K | Buy |
698
+426
| +157% | +$1.01K | ﹤0.01% | 1807 |
|
|
2019
Q1 | $1K | Sell |
272
-106
| -28% | -$459 | ﹤0.01% | 1919 |
|
|
2018
Q4 | $2K | Buy |
378
+187
| +98% | +$1.14K | ﹤0.01% | 1763 |
|
|
2018
Q3 | $2K | Buy |
191
+26
| +16% | +$250 | ﹤0.01% | 1737 |
|
|
2018
Q2 | $2K | Sell |
165
-334
| -67% | -$3.52K | ﹤0.01% | 1757 |
|
|
2018
Q1 | $5K | Buy |
+499
| New | +$4.93K | ﹤0.01% | 1420 |
|
|
2016
Q4 | – | Sell |
-599
| Closed | -$2K | – | 1306 |
|
|
2016
Q3 | $2K | Buy |
+599
| New | +$1.74K | ﹤0.01% | 1456 |
|
Other funds holding IMGN
SignatureFD's IMGN Position: Q1 2024 in Review
SignatureFD sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 670 shares — an estimated $19.9K sold.
SignatureFD first reported a position in IMGN in Q3 2016 and held it in 24 quarters. The position peaked at $19.9K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- SignatureFD reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- SignatureFD sold 670 Immunogen Inc shares in Q1 2024, an estimated $19.9K.
- SignatureFD first reported a position in Immunogen Inc in Q3 2016 and held it in 24 quarters.
- SignatureFD's Immunogen Inc position peaked at $19.9K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.